Department of Medicine
Adam DuVall specializes in the diagnosis and treatment of cancer for adolescents and young adults, with an emphasis on acute leukemias, lymphoma, and complex cancer predisposition syndromes, such as familial platelet disorder, hereditary anemias and bone marrow failure syndromes, and Li-Fraumeni syndrome. As part of the University of Chicago Medicine’s Adolescent and Young Adult Oncology Program, he provides comprehensive cancer care for teenage and young adult patients.
DuVall’s research explores the adaptation of new treatments and therapies into bedside care and the extension of novel therapies to the forefront of leukemia treatment. His collaboration with basic scientists allows him to examine new therapeutic options for genetic syndromes. He also participates in studies aimed at decreasing the impact of cancer therapy on the psychosocial development of his patients.
DuVall received MPH and MD degrees from Case Western Reserve University. He then completed an internal medicine and pediatrics residency at the University of Michigan, followed by a medical oncology fellowship at Oregon Health & Science University and a pediatric hematology/oncology fellowship at the affiliated Doernbecher Children’s Hospital.